Innovations in Population Health: Improving Outcomes for Patients with Chronic Kidney Disease.
Innovations in Population Health: Improving Outcomes for Patients with Chronic Kidney Disease.
复制标题
人口健康创新:改善慢性肾病患者的治疗结果。
DOI:
10.1089/pop.2023.0132
复制
发表时间:
2023
影响因子:
2.5
通讯作者:
Jhamb,Manisha
中科院分区:
文献类型:
--
作者:
Jhamb,Manisha
(CKD) has become an increasingly serious population health issue that affects 37 million Americans. 1 By 2030, an estimated 1 in every 6 adults age 30 and over will have CKD, with greater prevalence among persons who identify as Black or Hispanic. 1 Medicare spends $124 billion per year on CKD and end-stage kidney disease (ESKD), 1 and $90,000 per patient/per year for those on hemodialysis. 2 In addition to potentially widening pre-existing health disparities, the pandemic has had a measurable impact on CKD. Coronavirus disease 2019 (COVID-19) is directly associated with acute kidney injury in hospitalized patients, and the question of long-term effects has yet to be resolved. Indirect effects of COVID-19 include delays in care for related chronic diseases (diabetes and hypertension), food insecurity, and potential widening of the existing digital divide3 due to a shift toward telemedicine. 4 From a population perspective, there are two main challenges to providing care for CKD:(1) Identifying those at risk for disease progression that will require dialysis or transplant. The current prediction tools to identify high-risk patients have not been widely adopted in routine clinical practice. We need a real-time CKD risk predictor that is integrated into the electronic health record (EHR) and facilitates easy identification of high-risk patients.(2) Closing gaps in CKD care. Today there are> 3000 patients with CKD for every nephrologist. Primary care physicians (PCPs) provide most of the care. We need more efficient systems-based resources for PCPs to manage these complex patients.